It's as if these guys don't listen to each other.
(SUNW) blamed Europe on Tuesday for its reduction of revenue and earnings guidance for its current fiscal quarter. There have to be new excuses, of course. Now that there are not many breathing dot-coms to pick on, Sun no longer has that easy target. But those Europeans, they eat such rich, creamy sauces on their food. Yeah, that's it.
"Demand in Europe has tailed off more than we thought about six or seven weeks ago," said Mike Lehman, Sun's chief financial officer, in a thorough
for analysts of what ails Sun. "That's the news in this whole conference call."
And yet it was precisely six weeks ago that an executive just up the road from Sun's Palo Alto, Calif., headquarters predicted Europe would be next to weaken. In a conference call so brutal that the "it-couldn't-get-any-worse crowd" bid up the stock,
(SEBL) CEO Thomas Siebel
that Europe would begin to see as lousy a corporate IT spending climate as the U.S. had seen.
Siebel's best customers presumably overlap a bit with Sun's best accounts: Big businesses with big computing needs buy sophisticated software programs to manage their sales and customer-service functions as well as powerful servers to keep things humming. Lehman could have saved himself and Sun investors a lot of trouble by asking Tom Siebel what he was seeing six weeks ago that was so problematic in Europe.
For what it's worth, Siebel's shares rose 37% to $46.44 after it reported earnings on April 18. That proved to be overly exuberant, as those shares closed Thursday at $45.36. Sun's shares closed April 19 up 11% at $20.71. Thursday, Sun's shares set at $16.47, up 1% on the day.
Troika Was Worse Than Dead Money
Casual observers might believe that the fear
will disappoint investors in the quarter that closed Thursday is new news. In fact, it's just that
apparently had nothing else to discuss on a slow-news Thursday. But it was the topic of discussion here a month ago when
James J. Cramer
the troika of Sun,
and Oracle "dead money." Turns out it was worse. The troika traded for an average of $18.50 then; Thursday, the three had an average closing price of $17.01.
at the time that share
, of course, are meaningless. More meaningful, I argued, are relative valuations, and Oracle traded at a much lower multiple to its expected calendar 2001 earnings than the others. Interestingly, the situation hasn't changed much, despite the turmoil at Sun, the renewed enthusiasm for Cisco and the doubts about Oracle. Sun's stock, down 16% since May 4, actually trades at a higher multiple now because estimates of its earnings have fallen, from 35 cents per share a month ago to 25 cents today, according to
. Cisco's shares are flat; its earnings estimates actually have risen by a penny, and the forward multiple remains stratospheric, at 113 times current-year earnings.
But the real story remains Oracle, whose shares are down 8%, whose earnings estimates have been trimmed by just a penny, to 43 cents, and whose multiple remains relatively low, at 36 times current-year earnings forecasts, vs. 38 times in early May. Unless the company totally screws up, it's unusual for Oracle's shares to stay low for more than a year. Its valuation is reasonable only in comparison to its fellow fallen idols, of course, but it could start to look downright cheap for the long-term investor as each day goes by that it doesn't preannounce a lousy just-ended quarter.
Seeing Clearly at Research Frontiers
Wednesday on the 36-year-old development-stage company
noted that the firm is a favorite of short-sellers as well as more optimistic shareholders, many of whom like to mix it up on message boards devoted to the stock, affectionately known as Reefer, for its ticker. The fans have been emailing in force. Some of their questions and my answers follow:
Why did comments from licensees seem so uniformly negative? Well, Alex Martinez of aircraft replacement-window maker InspecTech Aero Service said the "smart window" technology Research Frontiers is peddling is so good his technical contacts at a major airline want to keep it away from the marketing folks, who will try to sell it too quickly. That's negative?
Why use old short-interest data? Good point. The short position has grown on Research Frontiers, meaning that investors have placed a larger bet the stock will fall. It stood at 892,000 on April 6, as noted, and at 1.1. million on May 15, according to Nasdaq.
Why repeat the company's claim of 360 patents without clarifying? Again, good point. Executive Vice President Joseph Harary made it clear to me that Research Frontiers has 360 patents and applications, though the company consistently plays up the strength of its hundreds of patents. David Miller, president and editor in chief of NymbleInvestor.com, an independent financial research site, says that his analysts determined that as of two years ago, the number of active patents was in the 40-something range. The balance were patent applications, many of which were duplicate overseas filings.